drugset / Trial / NCT01860625
A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects
RandomizedSingle-groupSingle-blindTreatment
Summary
Study of the Safety, tolerability and pharmacokinetics with single dose of donepezil patch in healthy male subjects.
Timeline
- Start
- 2013-04
- Primary completion
- 2013-12
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 43.75 mg | Other |
| Subject | Donepezil | Small molecule | 87.5 mg | Other |
| Subject | Donepezil | Small molecule | 175 mg | Other |